Welcome to the 2019 edition of the annual joint conference of the King Hussein Cancer Center, The American University of Beirut Medical Center, and MD Anderson Cancer Center.
Each year, researchers from the three institutions present the latest collaborative work in oncology research and standards of care, in addition to discussing prospective projects to be jointly pursued. In collaboration with MD Anderson Cancer Center, the King Hussein Cancer Center and the American University of Beirut Medical Center continue to lead the way in innovative medical research and education across the MENA region.
Conference Schedule
Day #1 -- 22 Mar, 2019
Hematologic Malignancies
| Time | Topic | Speaker |
|---|---|---|
| 8:25 | Welcome Remarks | Dr. Asem Mansour |
| Session-I | Moderators: Dr. Nazmi Kamal, Dr. Amal Abu Ghosh, Dr. Jean El-Cheikh | |
| 8:30-8:55 | Acute lymphocytic leukemia | Dr. HagopKantarjian |
| 8:55-9:20 | Acute Myeloid Leukemia | Dr. FarhadRavandi |
| 9:20-9:45 | Acute Myeloid Leukemia in Elderly | Dr. Amer Zeidan |
| 9:45-10:00 | Q&A | |
| 10:00-10:25 | Coffee Break & Poster View | |
| Session-2 | Moderators: Dr. Ahmad Telfah, Dr. Husam Abu Jazar, Dr. Khalid Halahleh | |
| 10:25-10:50 | Allogeneic Stem Cell Transplantation | Dr.Ali Bazarbachi |
| 10:50-11:15 | Chronic Myeloid Leukemia | Dr. HagopKantarjian |
| 11:15-11:40 | Myelodysplastic syndromes | Dr. Amer Zeidan |
| 11:40-11:50 | Q&A | |
| 11: 50- 1:10 | LUNCH and Jumah Prayers | |
| Session-3 | Moderators: Dr. Ali Bazerbashi, Dr. Sana Al-Sukhun, Dr. Abdelghani Tbakhi | |
| 1:10-1:35 | The Highly Curable Leukemia’s | Dr. FarhadRavandi |
| 1:35-2:00 | Multiple Myeloma | Dr. Sameer Yaser |
| 2:00-2:25 | Acute lymphocytic leukemia | Dr. HagopKantarjian |
| 2:25-2:50 | Update on CAR-T Therapy | Dr. Jean El-Cheikh |
| 2:50- 3:00 | Q&A | |
| 3:00-3:30 | Coffee Break & Poster View | |
| Session-4 | Moderators: Dr. Abdallah Al-Abbadi, Dr. Lina Marie, Dr. Salwa Saadeh |
| 3:30-3:40 | O-1; Comparable efficacy of peripheral stem cell mobilization using biosimilar G-CSF Nivestim(R) to original Neupogen(R) in healthy donors Dr. Rula Najjar |
| 3:42-3:52 | O-2; safety and efficacy of 4 cycles of BrentuximabVedotinas consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin’s lymphoma Dr. JeriesKort |
| 3:54-4:04 | O-3; The role of Anti-thymocyte globulin with Thiotepa-Busulfan-fludarabine based conditioning in patients undergoing haploidentical stem cell transplant and post-transplant cyclophosphamide. Dr. Jean El-Cheikh |
| 4:06-4:16 | O-4; Imatinibmesylate is safe and effective in maintaining cytogenetic and molecular response achieved with 1 year nilotinib first line in newly diagnosed chronic myeloid leukemia: preliminary results of a prospective clinical trial Dr. Nour M. Moukalled |
| 4:18-4:28 | O-5; Hematopoietic recovery and transfusion needs after Haploidentical stem cell transplantation with post-transplant cyclophosphamide in adult patients with hematologic malignancies Dr. Razan Mohty |
| 4:30-4:40 | O-6; The value of interim FDG- PET/CT in assessing response to therapy in Hodgkin Lymphoma patients at King Hussein Cancer Center (KHCC) Dr. Farah Anwer |
| 4:42-4:52 | O-7; Outcome of Relapsed Acute Lymphoblastic Leukemia in Children and Adolescent Treated At King Hussein Cancer Center Dr. Mayada Abu Shanap |
| 4:55-5:00 | Closing Remarks; Dr. HagopKantarjian |
| 5:00-5:30 | Reception |
| 5:30- 6:30 | Opening Ceremony |
Day #2 -- 23 Mar, 2019
Research Day
| Time | Hall-A/ Fourth Floor |
| 08:15-10:30 | Session-1/ Plenary Session |
| Moderators: Dr. Ali Taher, Dr. Mahmoud Al-Masri, Dr. Fady Geara; Dr. Ali Al Ebous | |
| 08:15-08:30 | Welcome Remarks |
| 08:30-08:40 | O-8; Activation of androgen receptor induces epithelial-to-mesenchymal transition of molecular apocrine breast MDA-MB-453 cancer cells: alterations of a molecular network Dr. Mamoun Ahram |
| 08:42-08:52 | O-9; Investigating the diagnostic accuracy of CT, 18F-FDG PET/CT and EBUS/TBNA in preoperative mediastinal nodal staging of NSCLC Dr.Akram Al-Ibraheem |
| 08:54-09:04 | O-10; Deep Targeted Sequencing Analysis of Hot Spot Mutations in Non-small Cell Lung Cancer Patients from the Levant Dr. Ghina Fakhri |
| 09:06-09:16 | O-11; Postmastectomy Radiation Therapy: “No One Size Fits All” Dr. Youssef H. Zeidan |
| 09:18-09:28 | O-12; Intravenous Ferric Carboxymaltose (FCM), without Erythropoiesis-Stimulating Agents (ESA), is Safe and Effective in the Treatment of Chemotherapy Induced Anemia (CIA) Dr. Hikmat Abdel-Razeq |
| 09:30-09:40 | O-13; Salvage chemotherapy using irinotecan and temozolamide in pediatric and adult populations with relapsed Ewing Sarcoma Dr. Samer Salah |
| 09:42-09:52 | O-14; CYR61/CCN1 Expression in Resected Pancreatic Adenocarcinoma Dr. Christelle Dagher |
| 09:54-10:04 | O-15; Modeling EGFR mutation detection for liquid biopsy Dr. Osama Alsmadi |
| 10:06-10:16 | O-16; Diagnostic Performance of FDG-PET/ CT scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Patients with Newly Diagnosed Breast Cancer Dr. Vanessa Akiki |
| 10:30-11:00 | Coffee Break and Poster View |
| Hall-A/ Fourth Floor | Hall-B/ Sixth Floor | |
| 11:00-13:00 | Session-2/ Breast Moderators: Dr. Hazem Assi, Dr. Said Al-Natour, Dr. Ghadeer Abdeen | Session-3/ Lung Moderators: Dr. Akram Al-Ibraheem, Dr. Feras Hawari, Dr. Abdulmajeed Dayyat |
| 11:00-11:28 | Year-in-Review; Dr. Nagi Al Saghair | Year-in-Review; Dr. Arafat Tfayli |
| 11:30-11:40 | O-17; Androgen receptor influences behavior of breast cancer cells via microRNAs: evidence of stronger transcriptional than post-transcriptional regulation Dr. Mamoun Ahram | O-24; Effect of PD-L1 Expression on Survival in Advanced Stage NSCLC Patients Harboring EGFR mutations and Receiving EGFR TKIs Dr. Kamal Alrabi |
| 11:42-11:52 | O-18; Genetic Counseling and Genetic Testing for Germline BRCA1/2 Mutations among High Risk Breast Cancer Patients in Jordan, a Study of 500 Patients Dr. Hikmat Abdel-Razeq | O-25; Prevalence of Programmed Death Ligand 1 in Patients Diagnosed with Non-Small Cell Lung Cancer in the Levant Majd Al-Assad |
| 11:54-12:04 | O-19; Availability, Rate of Usage, and Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early-Stage Breast Cancer Patients in Lebanon Dr. Nour Abdul Halim | O-26; Neutrophil Lymphocyte Ratio Association with Baseline Brain Metastasis in Stage IV Non-Small Cell Lung Cancer Dr. Kamal Alrabi |
| 12:06-12:16 | O-20; Breast Cancer among Elderly Jordanian Patients; Tumor Characteristics, Treatment Modalities and Outcomes Dr. Hikmat Abdel-Razeq | Session-4/ Genitourinary Moderators: Dr. Ali Al Daghmin, Dr. Imad Jaradat, Dr. Mohammad Salameh |
| 12:18:12:28 | O-21; Effectiveness of Cyanoacrylate (Glubran 2(R)) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection, Randomized controlled trial Dr. Mahmoud Al-Masri | O-27; Establishment and Characterization of Prostate Cancer Patient-derived Organoids and Cells Dr. Wassim Abou-Kheir |
| 12:30-12:40 | O-22; Amenorrhea and Fertility Preservation among Young Women Treated with Chemotherapy for Early-Stage Breast Cancer Dr. Omar Shahin | O-28; Prostate cancer (PC) in the Jordanian population: Disease trends and outcomes at King Hussein Cancer Center (KHCC) Dr. Amal Al-Omari |
| 12:42-12:52 | O-23; Fertility in Breast Cancer Survivors Following Breast Cancer Treatment at AUBMC: A Retrospective Study Dr. Rasha Kakati | O-29; EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence? Dr. Wassim Abou-Kheir |
| 13:00-14:00 | Lunch and Poster View | |
| 14:00-15:30 | Session-5/Supportive care Moderators: Dr. Sami Al-Khatib, Dr. Hussein Abu Khudair, Dr. Debrah Mukhraji | Session-6/ Pediatrics Moderators: Dr. Faris Madanat, Dr. Rawad Rihani, Dr. Hasan Hashem |
| 14:00-14:10 | O-30; Statin use improves the survival of colorectal cancer (CRC) patients in Jordan: An observational study at King Hussein Cancer Center (KHCC) Dr. Mahmoud A. Alfaqih | O-37; Differential Gene Expression of Neuroblastoma Identifies a Pattern that Predicts Prognosis and Highlights the Role of Transcription Factor Activating Protein 2 beta (TFAP2B) in Spontaneous Regression of Stage 4s Dr. Iyad Sultan |
| 14:12-14:22 | O-31; Predictors of Augmented Renal Clearance in Critically-Ill Patients with Cancer Dr. Lama Nazer | O-38; The Impact Of Retinoblastoma Screening Program for High Risk Children Dr. Yacoub A. Yousef |
| 14:24-14:34 | O-32; Impact of Using Perioperative Pulmonary Care Bundle on Postoperative Pulmonary Complications, Cancer Center Experience Dr. Riad Abdel Jalil | O-39; Rb Awareness among First Contact Physicians in Jordan Dr. Tamara Alnawaiseh |
| 14:36-14:46 | O-33; Fertility Counseling and Sperm Banking among Male Adolescents and Young Adults Treated for Cancer with Curative Intent in a Developing Country Dr. Hikmat Abdel-Razeq | Session-7/ Sarcoma Moderators: Dr. Abdulla Nofal, Dr. Faiha Bazzeh, Dr. Samer Abdel Al |
| 14:48-14:58 | O-34; High Incidence of Venous Thromboembolic Events (VTE) in Patients with Diffuse Large B-Cell Lymphoma (DLBL) Dr. Mohammad Ma’koseh | O-40; Timing of local control as a significant predictor of survival of patients with Ewing sarcoma of the extremities Dr. Samer Salah |
| 15:00-15:10 | O-35; Decision Making Preferences Among Patients with Advanced Cancer In A Tertiary Cancer Center in Jordan Dr. Mahmoud Abu Nasser | O-41; Quality Assurance Rounds for Sarcoma Radiotherapy Patients: Twelve-Year Results Dr. Ramiz Abu-Hijlih |
| 15:12-15:22 | O-36; Original filgrastim (Neupogen(R) and biosimilar filgrastim (Nivestim(R)): Comparison of effectiveness and safety in primary prophylaxis of chemotherapy-induced febrile neutropenia Dr. Suzan Hammoudeh | O-42; The Outcome of Limb Salvage Surgery in Developing Country, KHCC Experience Dr. Ahmad Shehadeh |
| 15:30-16:00 | Coffee Break and Poster View | |
| 16:00- | Hall-A/ Fourth Floor Session-8/General |
| Moderators: Dr. Faiez Daoud, Dr. Omar Shamieh, Dr. Abdulla Al-Rashdan | |
| 16:00-16:10 | O-43; Body Mass Index (BMI) and Long Term Outcomes in Patients with Colorectal Cancer (CRC) at King Hussein Cancer Center (KHCC) Dr. Amal Al-Omari |
| 16:12-16:22 | O-44; Laparoscopic versus open pancreaticoduodenectomy: a case-matched comparative study Dr. Balqees Al-Omari |
| 16:24-16:34 | O-45; Knowledge, Attitudes and Practices (KAP) of Cancer Patients towards Biobanking in Jordan: A study at King Hussein Cancer Center (KHCC) Dr. Maysa Al-Hussaini |
| 16:36-16:46 | O-46; Female oncologists in the Middle East and North Africa: progress towards gender equality Dr. Yolla Haibe |
| 16:48-16:58 | O-47; Cytoreduction and Hyperthermic intraperitoneal chemotherapy in Lebanese patients in a single institution. A retrospective study Dr. Muhieddine Seoud |
| 17:00-17:10 | O-48; Early Stage Oral Tongue Squamous Cell Carcinoma: Treatment Outcomes and Analysis of Recurrence Risk Factors Dr. Issa Mohamad |
| 17:12-17:20 | O-49; O-22; Laparoscopic versus open insertion of feeding gastrostomy tube in patients with head and neck cancers: a matched comparative study Dr. Basil Ammori |
| 17:22-17:32 | O-50; Clinical Characteristics and Treatment Outcome for Adult Medulloblastoma: A Tertiary Cancer Center Experience Dr. Abdelatif Almousa |
| 17:34-17:44 | O-51; Neuro-Onco-2; Prognostic Significance of O6-Methylguanine-DNA-methyltransferase (MGMT) Promoter Methylation and Isocitrate Dehydrogenase-1 (IDH-1) Mutation in Glioblastoma Multiforme Patients: A Single-Center Experience in the Middle East and North Africa (MENA) Region. Dr. Firas Kreidieh |
| 17:45-18:00 | Closing Remarks |
Registartion
KHCC, AUBMC or MD Anderson Cacner Center Memebers
FREE
- Plenary Sessions
- Workshops
- Conference Package
- Coffee Breaks and Lunch
- Certificate of Attendance
Regular
$100
- Plenary Sessions
- Workshops
- Conference Package
- Coffee Breaks and Lunch
- Certificate of Attendance
Venue
W Hotel, Amman, Jordan
Visit Hotel’s Website for more details.
To book a room and use KHCC’s promo code, please follow this link: Reserve Now
Amman, Jordan
Rafiq Al Hariri Ave 13, Amman 11953
20+ Speakers
Speakers from all over the world
Official Sponsors & Partners
Who make this conference possible!
Diamond Sponsors
Platinum Sponsors
Golden Sponsors
Silver Sponsors
The King Hussein Cancer Foundation
The King Hussein Cancer Foundation- Governing Body (The Foundation) is an independent, non-governmental, not-for-profit institution founded in 2001 by Royal Decree to combat cancer in Jordan and the Middle East region.
